PRODUCT DEVELOPMENT

Biolok''s product development emphasis is on scientific discovery, practical innovations, and improved patient outcomes. BioLok acquired Orthogen Corporation, now BioLok''s R&D Division, in 2000. Staffed by M.D.''s, P.h.D''s, and biomaterial engineers, Orthogen is focused on improving clinical out comes through advances in cell biology and biomaterials.